Choosing Surgical Prophylactic Antibiotics by Procedure

One of the most critical aspects of perioperative care is the appropriate selection of antibiotics to prevent surgical site infections (SSIs). For  anesthesia providers, understanding which antibiotics are most suitable for specific surgical procedures is key to reducing infection risks without contributing to antibiotic overuse and resistance.

Factors Influencing Antibiotic Selection 

Several factors influence the selection of antibiotics for surgical prophylaxis:

• Type of Surgery: The risk of infection varies depending on the nature of the surgical procedure. For example, clean surgeries (e.g., orthopedic or neurological procedures) generally carry a lower risk of infection compared to clean-contaminated (e.g., gastrointestinal or genitourinary surgeries) or contaminated surgeries (e.g., trauma or emergency surgeries). Each category has recommended antibiotic regimens to mitigate infection risks.
• Common Pathogens: Each surgical site has a typical spectrum of pathogens that are likely to cause infections. For instance, Gram-positive organisms, particularly Staphylococcus aureus and Staphylococcus epidermidis, are common in clean surgeries involving skin incisions. In contrast, Gram-negative bacteria and anaerobes are more prevalent in surgeries involving the gastrointestinal tract. Knowledge of these pathogens helps guide the choice of antibiotic coverage.
• Patient-Specific Factors: Age, comorbidities, allergies, and previous antibiotic exposure should also be considered. Patients with diabetes, obesity, or immunosuppression are at higher risk of infection and may require more tailored prophylactic strategies.

Standard Antibiotics for Surgical Prophylaxis 

• Cefazolin: For most clean procedures, cefazolin is the antibiotic of choice due to its broad-spectrum activity against Gram-positive bacteria and some Gram-negative organisms. Its long half-life and favorable safety profile make it a reliable option for procedures such as orthopedic, cardiovascular, and non-abdominal surgeries. The standard adult dose is 2 g IV (3 g for patients weighing 120 kg or more); children receive 30 mg/kg, not to exceed the adult dose.
• Cefoxitin and Cefotetan: In clean-contaminated surgeries that open the bowel or the genital tract, a second-generation cephamycin such as cefoxitin or cefotetan may be preferred because it adds Gram-negative and anaerobic coverage. These agents are commonly used in colorectal, appendiceal, and gynecologic surgery where exposure to intestinal flora is likely; cefazolin plus metronidazole is an equally accepted and now more common pairing for the same procedures. Cefuroxime is an alternative to cefazolin for cardiac and thoracic procedures but adds no anaerobic coverage.
• Vancomycin: In patients with known methicillin-resistant Staphylococcus aureus (MRSA) colonization, or in institutions with a high rate of MRSA surgical site infections, vancomycin (15 mg/kg IV, infused over at least 60 minutes) may be used. Because vancomycin is less active than cefazolin against methicillin-susceptible staphylococci, it is usually added to cefazolin rather than substituted for it. Its use is otherwise reserved for high-risk patients due to the potential for developing resistance.
• Metronidazole: For surgeries involving the gastrointestinal tract, where anaerobic bacteria are prevalent, metronidazole is often combined with other antibiotics to provide adequate anaerobic coverage. The usual adult dose is 500 mg IV.